Upcoming Events
DISCLAIMER: THIS SITE DOES NOT PROVIDE MEDICAL ADVICE
The information on this webpage and these webinars is intended for educational and informative purposes only and is not intended as a substitute for medical or professional advice, diagnosis or treatment. Always seek the advice of your doctor or other qualified health care provider with regards to any questions you may have regarding a medical condition or treatment before undertaking a health care regimen. Never disregard or delay seeking professional medical advice because of information you have read or seen on this website. The opinions stated in these webinars are those of the people speaking and not necessarily of AONM.
SPEAKER: Professor Douglas B. Kell CBE
TITLE: Fibrinaloid Microclot Complexes in Chronic Inflammatory Diseases such as Long COVID and M.E.
DATE: Tuesday 1st September
TIME: 19:00 BST | 20:00 CEST | 14:00 EDT
DESCRIPTION:
Long COVID, M.E. and other chronic inflammatory diseases continue to present significant challenges for both patients and clinicians. Could fibrinaloid microclots be one of the missing pieces of the puzzle?
In this upcoming AONM webinar, Professor Douglas Kell will explore the growing body of research surrounding fibrinaloid (amyloid fibrin) microclots and their potential role in impaired microcirculation, reduced oxygen delivery, and the persistent symptoms experienced in conditions such as Long COVID and M.E.
Drawing on decades of research and a programme of work that has helped shape our understanding of fibrinaloid microclots alongside Professor Resia Pretorius, Professor Kell will explain the biology behind these abnormal clots, why they may evade conventional testing, and what current evidence suggests about their role in chronic inflammatory disease.
The webinar will also discuss emerging approaches to supporting fibrinolysis, including the evidence surrounding enzymes and other candidate nutraceuticals, while emphasising the importance of working alongside healthcare professionals when considering any therapeutic interventions.
Whether you’re a healthcare practitioner, researcher, or someone with an interest in the latest developments in Long COVID and M.E. research, this webinar offers an evidence-informed overview of one of the most rapidly evolving areas of chronic disease research.
———————————————
ABOUT THE SPEAKER:
Professor Douglas B. Kell CBE studied Biochemistry at the University of Oxford, including a distinction in Chemical Pharmacology, before completing a DPhil at the same institution. He spent many years at the University of Aberystwyth before moving to the University of Manchester (UMIST) in 2002, where he led the Manchester Centre for Integrative Systems Biology. He moved to the University of Liverpool in 2018 and is a Founding Director of Aber Instruments Ltd (recipient of the Queen’s Award for Export Achievement in 1998). He also served as Chief Executive of the Biotechnology and Biological Sciences Research Council (BBSRC) from 2008–2013.
Professor Kell has authored 573 scientific papers and is internationally recognised for his contributions to systems biology, biotechnology and chronic disease research.
In recent years, Professor Kell has focused on the role of fibrinaloid microclots in Long COVID, M.E./CFS and other chronic inflammatory diseases. Working closely with Professor Resia Pretorius, his research has helped advance our understanding of how these abnormal clots may contribute to chronic illness and is helping to inform future diagnostic and therapeutic approaches.
For those interested in exploring his research further, Professor Kell regularly shares updates and publications via his research blog:
http://dbkgroup.org/longcovid/
———————————————
Registration link: www.aonm.org/KellSeptember
SPEAKER: Gilian Crowther MA (Oxon), FBANT, mANP, mNNA, CNHC reg.
TITLE: The Links Between Autoimmunity and Infections: Part 2
DATE: Tuesday 8th September 2026
TIME: 19:00 BST | 20:00 CEST | 14:00 EDT
DESCRIPTION:
Autoimmune diseases are often viewed as conditions where the immune system mistakenly attacks the body. But could underlying infections be one of the missing pieces of the puzzle?
In this upcoming AONM webinar, Gilian Crowther, AONM’s Director of Research and an experienced Nutritional Therapist, explores the growing body of evidence linking chronic infections with the development and progression of autoimmune diseases.
Drawing on the latest scientific research, alongside many years of clinical and laboratory experience working with ArminLabs in Germany, Gilian will discuss how identifying and addressing underlying infections may help practitioners better understand and support individuals with autoimmune conditions.
In this second part of the series, you’ll discover:
- The evidence linking infections with autoimmune diseases
- The potential role of infections in inflammatory bowel disease, Sjögren’s syndrome, myasthenia gravis, and Guillain-Barré syndrome
- Laboratory testing that can help identify underlying infectious triggers
- How this knowledge can inform a more personalised approach to patient care
Whether you’re a healthcare practitioner looking to deepen your understanding of autoimmunity, or you’re interested in the emerging research surrounding infectious drivers of chronic disease, this webinar offers an evidence-informed perspective on an increasingly important area of functional and nutritional medicine.
———————————————
ABOUT THE SPEAKER:
Gilian Crowther MA (Oxon), FBANT, mANP, mNNA, CNHC reg. is a fully qualified Naturopath and Nutritional Therapist.
Her key areas of focus are infectious pathologies and mitochondrial dysfunction. She studied complementary therapy in Germany for many years before completing her training in the UK.
She has been a senior member of AONM (the Academy of Nutritional Medicine, https://www.aonm.org) since 2010 and is the organisation’s Director of Research.
She is also a committee member of the General Naturopathic Council (GNC) and the British Society for Ecological Medicine (BSEM).
———————————————
Registration link: www.aonm.org/SeptemberCrowther